BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21462089)

  • 1. Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions.
    Tran VH; Marks D; Duke RK; Bebawy M; Duke CC; Roufogalis BD
    Nutr Cancer; 2011; 63(3):435-43. PubMed ID: 21462089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance-modifying components in human plasma with potential clinical significance.
    Mülder HS; Pinedo HM; Timmer AT; Rao BR; Lankelma J
    J Exp Ther Oncol; 1996 Jan; 1(1):13-22. PubMed ID: 9414384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
    den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
    Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.
    Chearwae W; Anuchapreeda S; Nandigama K; Ambudkar SV; Limtrakul P
    Biochem Pharmacol; 2004 Nov; 68(10):2043-52. PubMed ID: 15476675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D; Eriksen J; Maare C; Friche E; Skovsgaard T
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):453-60. PubMed ID: 12107549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship and mechanism of flavonoids on the inhibitory activity of P-glycoprotein (P-gp)-mediated transport of rhodamine123 and daunorubicin in P-gp overexpressed human mouth epidermal carcinoma (KB/MDR) cells.
    Fang Y; Liang F; Xia M; Cao W; Pan S; Wu T; Xu X
    Food Chem Toxicol; 2021 Sep; 155():112381. PubMed ID: 34217736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.
    Critchfield JW; Welsh CJ; Phang JM; Yeh GC
    Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation.
    Chan KF; Wong IL; Kan JW; Yan CS; Chow LM; Chan TH
    J Med Chem; 2012 Mar; 55(5):1999-2014. PubMed ID: 22320402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
    Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
    Zhang S; Morris ME
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1258-67. PubMed ID: 12604704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1.
    Tajima Y; Nakagawa H; Tamura A; Kadioglu O; Satake K; Mitani Y; Murase H; Regasini LO; Bolzani Vda S; Ishikawa T; Fricker G; Efferth T
    Phytomedicine; 2014 Feb; 21(3):323-32. PubMed ID: 24135452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs.
    Galmarini CM
    J Exp Ther Oncol; 2002; 2(3):146-52. PubMed ID: 12415630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
    Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
    Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
    Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.